Literature DB >> 36161553

The handling of missing data in trial-based economic evaluations: should data be multiply imputed prior to longitudinal linear mixed-model analyses?

Ângela Jornada Ben1, Johanna M van Dongen2, Mohamed El Alili2, Martijn W Heymans3, Jos W R Twisk3, Janet L MacNeil-Vroomen4, Maartje de Wit5, Susan E M van Dijk2, Teddy Oosterhuis6, Judith E Bosmans2.   

Abstract

INTRODUCTION: For the analysis of clinical effects, multiple imputation (MI) of missing data were shown to be unnecessary when using longitudinal linear mixed-models (LLM). It remains unclear whether this also applies to trial-based economic evaluations. Therefore, this study aimed to assess whether MI is required prior to LLM when analyzing longitudinal cost and effect data.
METHODS: Two-thousand complete datasets were simulated containing five time points. Incomplete datasets were generated with 10, 25, and 50% missing data in follow-up costs and effects, assuming a Missing At Random (MAR) mechanism. Six different strategies were compared using empirical bias (EB), root-mean-squared error (RMSE), and coverage rate (CR). These strategies were: LLM alone (LLM) and MI with LLM (MI-LLM), and, as reference strategies, mean imputation with LLM (M-LLM), seemingly unrelated regression alone (SUR-CCA), MI with SUR (MI-SUR), and mean imputation with SUR (M-SUR).
RESULTS: For costs and effects, LLM, MI-LLM, and MI-SUR performed better than M-LLM, SUR-CCA, and M-SUR, with smaller EBs and RMSEs as well as CRs closers to nominal levels. However, even though LLM, MI-LLM and MI-SUR performed equally well for effects, MI-LLM and MI-SUR were found to perform better than LLM for costs at 10 and 25% missing data. At 50% missing data, all strategies resulted in relatively high EBs and RMSEs for costs.
CONCLUSION: LLM should be combined with MI when analyzing trial-based economic evaluation data. MI-SUR is more efficient and can also be used, but then an average intervention effect over time cannot be estimated.
© 2022. The Author(s).

Entities:  

Keywords:  Computer simulation; Cost–benefit analysis; Epidemiologic methods; Longitudinal studies

Year:  2022        PMID: 36161553     DOI: 10.1007/s10198-022-01525-y

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  37 in total

1.  Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data.

Authors:  Andrew R Willan; Andrew H Briggs; Jeffrey S Hoch
Journal:  Health Econ       Date:  2004-05       Impact factor: 3.046

2.  Missing data in trial-based cost-effectiveness analysis: the current state of play.

Authors:  Sian Marie Noble; William Hollingworth; Kate Tilling
Journal:  Health Econ       Date:  2010-12-15       Impact factor: 3.046

3.  Multiple imputation of missing repeated outcome measurements did not add to linear mixed-effects models.

Authors:  Sanne A E Peters; Michiel L Bots; Hester M den Ruijter; Mike K Palmer; Diederick E Grobbee; John R Crouse; Daniel H O'Leary; Gregory W Evans; Joel S Raichlen; Karel G M Moons; Hendrik Koffijberg
Journal:  J Clin Epidemiol       Date:  2012-03-27       Impact factor: 6.437

4.  Multiple imputation of missing values was not necessary before performing a longitudinal mixed-model analysis.

Authors:  Jos Twisk; Michiel de Boer; Wieke de Vente; Martijn Heymans
Journal:  J Clin Epidemiol       Date:  2013-06-21       Impact factor: 6.437

Review 5.  Statistical methods for cost-effectiveness analyses that use data from cluster randomized trials: a systematic review and checklist for critical appraisal.

Authors:  Manuel Gomes; Richard Grieve; Richard Nixon; W J Edmunds
Journal:  Med Decis Making       Date:  2011-05-24       Impact factor: 2.583

6.  Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls.

Authors:  Jonathan A C Sterne; Ian R White; John B Carlin; Michael Spratt; Patrick Royston; Michael G Kenward; Angela M Wood; James R Carpenter
Journal:  BMJ       Date:  2009-06-29

7.  Perinatal and maternal outcomes by planned place of birth for healthy women with low risk pregnancies: the Birthplace in England national prospective cohort study.

Authors:  Peter Brocklehurst; Pollyanna Hardy; Jennifer Hollowell; Louise Linsell; Alison Macfarlane; Christine McCourt; Neil Marlow; Alison Miller; Mary Newburn; Stavros Petrou; David Puddicombe; Maggie Redshaw; Rachel Rowe; Jane Sandall; Louise Silverton; Mary Stewart
Journal:  BMJ       Date:  2011-11-23

8.  A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials.

Authors:  Rita Faria; Manuel Gomes; David Epstein; Ian R White
Journal:  Pharmacoeconomics       Date:  2014-12       Impact factor: 4.981

9.  Should multiple imputation be the method of choice for handling missing data in randomized trials?

Authors:  Thomas R Sullivan; Ian R White; Amy B Salter; Philip Ryan; Katherine J Lee
Journal:  Stat Methods Med Res       Date:  2016-12-19       Impact factor: 3.021

Review 10.  Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: A Review with Future Recommendations.

Authors:  Andrea Gabrio; Alexina J Mason; Gianluca Baio
Journal:  Pharmacoecon Open       Date:  2017-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.